implantable News

The Revo MRI™ SureScan® pacing system, the first and only pacemaker in the U.S. specifically designed for use in a MRI environment, was approved by the U.S. Food and Drug Administration (FDA) On February 8, 2011.

New Medical Devices market report from GlobalData: "GT Urological, LLC - Product Pipeline Analysis"

“The patients who receive this implant can benefit from the pacemaker’s size, durability and novel rate regulation algorithm. It also has real-time, cellular-based home monitoring,” said Dr. Kanner.

This report discusses US implantable and transdermal drug delivery systems for the years 2001 and 2006, with forecasts for 2011.